Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined
- 1 June 1995
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (6) , 1175-1180
- https://doi.org/10.1038/bjc.1995.229
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerationsBritish Journal of Cancer, 1993
- Radiosensitization by nicotinamide in tumors and normal tissues: The importance of tissue oxygenation statusInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Tumor Radiosensitization by Nicotinamide: A Result of Improved Perfusion and OxygenationRadiation Research, 1989
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Radiosensitization by Nicotinamide in Vivo: A Greater Enhancement of Tumor Damage Compared to That of Normal TissuesRadiation Research, 1987
- A New Mouse Tumor Model System (RIF-1) for Comparison of End-Point Studies23JNCI Journal of the National Cancer Institute, 1980
- Carbogen breathing during radiation therapy The radiation therapy oncology group studyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcomaInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinomaCancer, 1972
- Blood flow and oxygenation of tumors in mice.I. Effects of breathing gases containing carbon dioxide at atmospheric pressureCancer, 1967